Comment on "Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry"

Affiliations

¹ Department of Gastroenterology, Luigi Sacco Hospital, University of Milan, Milan, Italy. Electronic address: sofia.ridolfo@unimi.it.
² Department of Gastroenterology, Luigi Sacco Hospital, University of Milan, Milan, Italy.
³ Department of Gastroenterology, Luigi Sacco Hospital, University of Milan, Milan, Italy; Department of Biomedical and Clinical Sciences, Luigi Sacco, University of Milan, Milan, Italy.

Comment

Sofia Ridolfo et al. Dig Liver Dis. 2023 Sep.

. 2023 Sep;55(9):1304.

doi: 10.1016/j.dld.2023.03.012. Epub 2023 Apr 14.

¹ Department of Gastroenterology, Luigi Sacco Hospital, University of Milan, Milan, Italy. Electronic address: sofia.ridolfo@unimi.it.
² Department of Gastroenterology, Luigi Sacco Hospital, University of Milan, Milan, Italy.
³ Department of Gastroenterology, Luigi Sacco Hospital, University of Milan, Milan, Italy; Department of Biomedical and Clinical Sciences, Luigi Sacco, University of Milan, Milan, Italy.

No abstract available

Keywords: Crohn's disease; Endoscopic postoperative recurrence; Ustekinumab.

Comment on

Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry.
Mañosa M, Fernández-Clotet A, Nos P, Martín-Arranz MD, Manceñido N, Carbajo A, Hinojosa E, Hernández-Camba A, Muñoz-Pérez R, Boscá-Watts M, Calvo M, Sierra-Ausín M, Sánchez-Rodríguez E, Barreiro-de Acosta M, Núñez-Alonso A, Zabana Y, Márquez L, Gisbert JP, Guardiola J, Sáinz E, Delgado-Guillena P, Busquets D, van Domselaar M, Girona E, Lorente R, Casas-Deza D, Huguet JM, Maestro S, Cabello MJ, Castro J, Iborra M, Cañete F, Calafat M, Domènech E; ENEIDA registry by GETECCU. Mañosa M, et al. Dig Liver Dis. 2023 Jan;55(1):46-52. doi: 10.1016/j.dld.2022.07.013. Epub 2022 Aug 7. Dig Liver Dis. 2023. PMID: 35948459